These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38942524)
1. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders. Rovira À; Vidal-Jordana A; Auger C; Sastre-Garriga J Neuroimaging Clin N Am; 2024 Aug; 34(3):399-420. PubMed ID: 38942524 [TBL] [Abstract][Full Text] [Related]
2. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. Bianchi A; Cortese R; Prados F; Tur C; Kanber B; Yiannakas MC; Samson R; De Angelis F; Magnollay L; Jacob A; Brownlee W; Trip A; Nicholas R; Hacohen Y; Barkhof F; Ciccarelli O; Toosy AT Mult Scler; 2024 May; 30(6):674-686. PubMed ID: 38646958 [TBL] [Abstract][Full Text] [Related]
3. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review. Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073 [TBL] [Abstract][Full Text] [Related]
4. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica. Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974 [TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging helps differentiate multiple sclerosis and neuromyelitis optica-related acute optic neuritis. Wan H; He H; Zhang F; Sha Y; Tian G J Magn Reson Imaging; 2017 Jun; 45(6):1780-1785. PubMed ID: 27859858 [TBL] [Abstract][Full Text] [Related]
6. Optic neuritis in the era of biomarkers. Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702 [TBL] [Abstract][Full Text] [Related]
7. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301 [TBL] [Abstract][Full Text] [Related]
8. MRI Characteristics of NMO, MOG and MS Related Optic Neuritis. Winter A; Chwalisz B Semin Ophthalmol; 2020 Nov; 35(7-8):333-342. PubMed ID: 33395326 [TBL] [Abstract][Full Text] [Related]
9. Critical review: Typical and atypical optic neuritis. Abel A; McClelland C; Lee MS Surv Ophthalmol; 2019; 64(6):770-779. PubMed ID: 31229520 [TBL] [Abstract][Full Text] [Related]
10. [Clinical phenotypes of optic nerve damage in patients with neuromyelitis optica spectrum disorder]. Svetozarskiy SN; Kopishinskaya SV; Ruina EA; Antipenko EA Vestn Oftalmol; 2023; 139(2):61-67. PubMed ID: 37067933 [TBL] [Abstract][Full Text] [Related]
11. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165 [TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis Optica Spectrum Disorders. Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis. Tajfirouz DA; Bhatti MT; Chen JJ Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369 [TBL] [Abstract][Full Text] [Related]
14. Clinical and neuroimaging findings in MOGAD-MRI and OCT. Bartels F; Lu A; Oertel FC; Finke C; Paul F; Chien C Clin Exp Immunol; 2021 Dec; 206(3):266-281. PubMed ID: 34152000 [TBL] [Abstract][Full Text] [Related]